Indeed, in the paper by Baron et al.,20 it is shown that in an Alzheimer's disease model, genetically engineered for producing limited amounts of IFNγ, neurogenesis is enhanced. The gene discussed is IFNG; the disease is early-onset autosomal dominant Alzheimer disease.